Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Dermatologic 1

Conditions

Colorectal Neoplasms 45Stomach Neoplasms 20Pancreatic Neoplasms 20Rectal Neoplasms 16Adenocarcinoma Of Esophagus 14Esophageal Neoplasms 13Colonic Neoplasms 12Neoplasms 11Neoplasm Metastasis 11Carcinoma, Non-Small-Cell Lung 11Urinary Bladder Neoplasms 8Squamous Cell Carcinoma of Head and Neck 8Esophageal Squamous Cell Carcinoma 7Adenocarcinoma 7Ovarian Neoplasms 5Cholangiocarcinoma 5Parkinson Disease 4, Autosomal Dominant Lewy Body 4Lung Neoplasms 4Gastrointestinal Neoplasms 4Endometrial Neoplasms 4Carcinoma 4Head and Neck Neoplasms 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Biliary Tract Neoplasms 3Advanced Solid Tumors 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Oropharyngeal Neoplasms 2Melanoma 2

Interventions

folfirinox 1Taxes 1Oxaliplatin 1Leucovorin 1Irinotecan 1HhAntag691 1Gemcitabine 1Fluorouracil 1Erlotinib Hydrochloride 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Basal Cell × Fluorouracil × 90 days × Clear all
NCT06483555 2026-04-23

PANGEA

UNC Lineberger Comprehensive Cancer Center

Phase 1/2 Recruiting
104 enrolled
DermatologicGastrointestinal

Pancreatic Neoplasms, Neoplasms, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡